ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.704,42
-0,11%
S&P 500
5.303,27
0,12%
Dow Jones
40.003,59
0,34%
Euro vs US Dollar
1,08955
0,26%
Bitcoin
66.771,31
2,35%
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Protagonist Therapeutics Inc (PTGX)

  7. Protagonist Therapeutics Inc (PTGX) News

PTGX

Protagonist Therapeutics (PTGX)

Protagonist Therapeutics Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:PTGX
DatumZeitQuelleÜberschriftSymbolFirma
07/05/202422h51Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PTGXProtagonist Therapeutics Inc
07/05/202422h29Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PTGXProtagonist Therapeutics Inc
16/04/202415h00GlobeNewswire Inc.Turnstone Biologics Appoints William Waddill to its Board of DirectorsNASDAQ:PTGXProtagonist Therapeutics Inc
02/03/202402h45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PTGXProtagonist Therapeutics Inc
02/03/202402h45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PTGXProtagonist Therapeutics Inc
02/03/202402h27Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PTGXProtagonist Therapeutics Inc
01/03/202422h32Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PTGXProtagonist Therapeutics Inc
29/02/202423h48Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PTGXProtagonist Therapeutics Inc
29/02/202402h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PTGXProtagonist Therapeutics Inc
27/02/202422h12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PTGXProtagonist Therapeutics Inc
14/02/202413h47Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:PTGXProtagonist Therapeutics Inc
14/02/202413h15Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:PTGXProtagonist Therapeutics Inc
31/01/202422h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PTGXProtagonist Therapeutics Inc
19/01/202402h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PTGXProtagonist Therapeutics Inc
19/01/202402h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PTGXProtagonist Therapeutics Inc
16/01/202414h01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PTGXProtagonist Therapeutics Inc
12/01/202402h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PTGXProtagonist Therapeutics Inc
09/01/202423h25Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PTGXProtagonist Therapeutics Inc
08/01/202414h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PTGXProtagonist Therapeutics Inc
05/01/202402h17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PTGXProtagonist Therapeutics Inc
05/01/202402h17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PTGXProtagonist Therapeutics Inc
05/01/202402h15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PTGXProtagonist Therapeutics Inc
05/01/202402h14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PTGXProtagonist Therapeutics Inc
05/01/202402h10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PTGXProtagonist Therapeutics Inc
05/01/202402h09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PTGXProtagonist Therapeutics Inc
05/01/202402h07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PTGXProtagonist Therapeutics Inc
18/12/202322h15Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:PTGXProtagonist Therapeutics Inc
02/11/202322h07Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PTGXProtagonist Therapeutics Inc
02/11/202321h40Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PTGXProtagonist Therapeutics Inc
30/10/202321h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PTGXProtagonist Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:PTGX

Kürzlich von Ihnen besucht

ASX
SPFKOE
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten